- About Us
- Guidelines
-
The Author ensures that the research has been conducted responsibly and ethically with adherence to all relevant regulations. read more..
- For Authors
- For Reviewer
- Manuscript Guidelines
- Membership
-
- Journals
- Reprints
- e-Books
- Videos
- Indexing
- Contact Us
COVID-19
- Submissions
Abstract
Techniques in Neurosurgery & Neurology
Recent Advances in the Treatment of Opioid Use Disorders
-
Open or CloseMichael Soyka*
Psychiatry Hospital, University of Munich, Nußbaumstr. 7, 80336 Munich, Germany
*Corresponding author:Michael Soyka, Psychiatry Hospital, University of Munich, Nußbaumstr. 7, 80336 Munich, Germany
Submission: November 11, 2020 Published: December 16, 2020
ISSN 2637-7748Volume3 Issue5
Abstract
For pharmacotherapy of opioid use disorders treatment with oral methadone or sublingual buprenorphine are established first-line treatments. Recently three novel long-acting buprenorphine depot or implant formulations have been studieD and in part approved for treatment of opioid use disorders: for subcutaneous weekly and monthly application the depot formulations CAM 2038 [Buvidal®], the monthly depot formulation RBP-6000 [Sublocade™] and the six-month buprenorphine implant [Probuphine™]. The pharmacology and efficacy of these novel medications will be reviewed and discussed
Keywords: Opioids; Opioid dependence;Maintenance treatment;Methadone;Buprenorphine;Depot;Implant
Editor In Chief
.jpg)
Signup for Newsletter
Quick Links
Editorial Board Registrations
Submit your Article
Best Paper of the Volume
Reprints
Refer a Friend
Advertise With UsOur Recent Edition
.jpg)
Top Editors
.jpg)
.bmp)
.jpg)
.png)
.jpg)
.png)
.png)
.png)
Financial Support
Sponsors
Latest e-Books
Latest Video
a Creative Commons Attribution 4.0 International License. Based on a work at www.crimsonpublishers.com.
Best viewed in 
| Above IE 9.0 version